Tag: pr
-
Human controls, standards needed for artificial intelligence, experts say
Artificial intelligence is likely to transform the public sector by automating many government tasks—including making combat decisions. But, according to experts at a recent symposium held at Harvard University, this “over-the-horizon” technology can only guide and inform government leaders. There will always be a need for human decision making—and for clear ethical standards to prevent…
-
Georgia O’Keeffe Inspirational at the Peabody Essex
Cambridge writer Anita Harris felt inspired by the Georgia O’keeffe show at the Peabody Essex Museum in Salem, MA–which exhibits the work of a groundbreaking artist who lived and worked into her late 90s, and whose work remains impactful, today.
-
Italian Life Science Innovators to present at Venture Cafe, Cambridge, Oct. 22
Mass Global Partners and the Italian Trade Agency cordially invite New Cambridge Observer readers and others to “Discover 13 of Italy’s most Innovative early stage life science companies developing therapeutics, devices and tools” October 22, 2015, in Kendall Square, Cambridge
-
Guest Post: Ithaca Diaries author Anita Harris interviewed on NPR’s “Here and Now”
In an interview with Lisa Mullins on “Here and Now” a daily program of National Public Radio, author Anita Harris reflected on how her college years shaped her career path. The interview focused on Harris’s book, Ithaca Diaries, a memoir and social history of her years at Cornell University in the 1960s.
-
BTW founder and SkeleTom sweat reaching kickstarter goal
With her own kickstarter still in progress, author Anita M. Harris congratulates BTW’s Harold Simansky for reaching BTW’s kickstarter goal. They both know you can feel like you’re growing as old as SkelTom while waiting for contributions to roll in.
-
Paris/Cambridge Ariana Pharma Joins Worldwide Cancer Network WIN
Cambridge-Paris Ariana Pharma reports that it has joined the WIN Consortium as an official technology partner. The Consortium (Worldwide Innovative Networking in personalized cancer medicine) is a global collaboration of 40 leading organizations whose aim is to develop more effective cancer diagnostics and therapeutics, shorten clinical trial timelines and reduce the overall cost of cancer…